Loading...

CohBar Provides Update on CB4211 Phase 1b Study for NASH and Obesity

Print Friendly, PDF & Email

MITO-RELATED CLINICAL STUDY UPDATE:

COVID-19 Pandemic Impact at Clinical Sites Delays Study MENLO PARK, Calif., March 30, 2020 (GLOBE NEWSWIRE) — CohBar, Inc. ( CWBR ), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, today announced that it is anticipating delays in the completion […]